|
July 2020 Corporate Presentation and Webcast July 16th
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 13, 2020 11:04AM
|
|
Re: Bioasis Announces Filing of Its Fourth Quarter and Fiscal Year-End Financial Statements and MD&A
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jun 26, 2018 09:23PM
|
|
Re: Patient Enrollment Modeling
|
2
|
Resverlogix Corp.
|
Dec 02, 2018 05:44PM
|
|
Re: Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism
|
2
|
Resverlogix Corp.
|
May 24, 2016 04:48PM
|
|
Re: ACC 2019 Abstracts
|
2
|
Resverlogix Corp.
|
Mar 04, 2019 11:30PM
|
|
Re: AEGIS-II trial
|
2
|
Resverlogix Corp.
|
Mar 22, 2018 01:29PM
|
|
Re: Zenith Presentation Tuesday
|
2
|
Zenith Epigenetics
|
Oct 13, 2017 07:10PM
|
|
Re: Led
|
2
|
Resverlogix Corp.
|
Jan 29, 2016 01:19PM
|
|
Re: Endocyte Valuation
|
2
|
Zenith Epigenetics
|
Oct 18, 2018 02:54PM
|
|
Re: ESPR
|
2
|
Resverlogix Corp.
|
May 04, 2016 11:39AM
|
|
ZEN-3694 level up
|
2
|
Zenith Epigenetics
|
Oct 05, 2016 02:24PM
|
|
Re: As seen on Investor Village
|
2
|
Resverlogix Corp.
|
Dec 10, 2019 09:15PM
|
|
Re: New price level when they announce 250 MACE Events,...?
|
2
|
Resverlogix Corp.
|
Jan 09, 2019 12:47PM
|
|
Re: 2019 Potential Events
|
2
|
Resverlogix Corp.
|
Jan 16, 2019 10:44AM
|
|
Re: Effects of the BET-inhibitor, RVX-208 on the HDL lipidome and glucose metabolism
|
2
|
Resverlogix Corp.
|
May 24, 2016 05:06PM
|
|
Re: Resverlogix Closes Previously Announced $87 Million Private Placement with Shenzhen Hepalink
|
2
|
Resverlogix Corp.
|
Dec 04, 2017 02:31PM
|
|
Re: RVX-208 and Rosuvastatin Patent
|
2
|
Resverlogix Corp.
|
Dec 13, 2016 02:39PM
|
|
Re: EAS Poster Sessions Apabetalone is there
|
2
|
Resverlogix Corp.
|
Apr 15, 2017 10:10AM
|
|
Re: Apabetalone's impact on blood pressure
|
2
|
Resverlogix Corp.
|
Feb 23, 2019 04:53PM
|
|
Re: Zenith
|
2
|
Resverlogix Corp.
|
Dec 10, 2019 09:22PM
|
